ASHP Therapeutic Position Statement on the Use of Antipsychotic Medications in the Treatment of Adults with Schizophrenia and Schizoaffective Disorder (original) (raw)

Antipsychotic Medication for Early-Episode Schizophrenia

John Bola

Schizophrenia Bulletin, 2011

View PDFchevron_right

Attitudes Toward Antipsychotic Medication

David Healy

Archives of General Psychiatry, 2005

View PDFchevron_right

Use of second-generation antipsychotics in the acute inpatient management of schizophrenia in the Middle East

Nasser Al Zain

Neuropsychiatric Disease and Treatment, 2015

View PDFchevron_right

Adverse Drug Reactions Affiliated with Atypical Antipsychotics in Patients with Schizophrenia

shweta oommen

Journal of Young Pharmacists, 2019

View PDFchevron_right

Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients

Eva Peñas Lledó

European Journal of Clinical Pharmacology, 2007

View PDFchevron_right

Use and Safety of Antipsychotics in Behavioral Disorders in Elderly People With Dementia

Giovambattista Sarro

Journal of Clinical Psychopharmacology, 2014

View PDFchevron_right

Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders

Noosha Niv

CNS Drugs, 2008

View PDFchevron_right

Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults

Lissette Saavedra

2012

View PDFchevron_right

Clinical Characteristics of Patients With Schizophrenia Who Successfully Discontinued Antipsychotics

Takefumi Suzuki

Journal of Clinical Psychopharmacology, 2018

View PDFchevron_right

Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

Alison Markwick

Schizophrenia Bulletin, 2005

View PDFchevron_right

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

Isabell Heuser

Schizophrenia Research, 2010

View PDFchevron_right

Long-Acting Risperidone and Oral Antipsychotics in Schizophrenia

Robert Rosenheck

New England Journal of Medicine, 2011

View PDFchevron_right

Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data

Anatoly Kreinin

View PDFchevron_right

Management of Adverse Effects of Second-generation Antipsychotics in Youth

Marianna Giannitelli

Current Treatment Options in Psychiatry, 2014

View PDFchevron_right

Effectiveness of clozapine in treatment-resistant schizophrenia

Raguraman Janakiraman

Indian Journal of Psychiatry, 2005

View PDFchevron_right

Antipsychotics and their side effects

HASSAN MIRZA

Journal of Mental Health, 2011

View PDFchevron_right

Antipsychotic Drugs

Melissa Piasecki

Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery

View PDFchevron_right

Comparing Antipsychotic Treatments for Schizophrenia: A Health State Approach

Robert Rosenheck

Psychiatric Quarterly, 2014

View PDFchevron_right

Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia

Jari Tiihonen

JAMA Psychiatry, 2019

View PDFchevron_right

Treatment Guidelines for Patients with Schizophrenia or Psychotic Disorder who are Hospitalized in a Psychiatry Clinic

Dr. Hülya Ensari

Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 2014

View PDFchevron_right

Common Use of Antipsychotic Polypharmacy in Older Asian Patients With Schizophrenia (2001–2009)

Chay hoon Tan

Journal of Clinical Psychopharmacology, 2012

View PDFchevron_right

Clozapine versus other atypical antipsychotics for schizophrenia

Claudia Asenjo-Lobos

Cochrane Database of Systematic Reviews, 2010

View PDFchevron_right

The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review

Fabian Lungu

Brain sciences, 2024

View PDFchevron_right

In Response to "The neuroleptic treatment of schizophrenia: dosing strategies, depot preparations and novel medications" by Alexander S. Young, M.D. (volume 13, 18-26)

Joseph Cassar

Jefferson Journal of Psychiatry, 1998

View PDFchevron_right

Doubtful association of antipsychotic polypharmacy and high dosage with cognition in chronic schizophrenia

S. Kleisas

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010

View PDFchevron_right

Antipsychotic prescription trends according to ethnicity

Aqeel Hashmi

Psychiatric Bulletin, 2009

View PDFchevron_right

Neurological Adverse Effects of Antipsychotics in Children and Adolescents

cecilia tapia

Journal of Clinical Psychopharmacology, 2015

View PDFchevron_right

Maintenance antipsychotic medication patterns in outpatient schizophrenia patients: a naturalistic cohort study

Richard Laugharne

Acta Psychiatrica Scandinavica, 2006

View PDFchevron_right

Experience of VA Psychiatrists With Pharmaceutical Detailing of Antipsychotic Medications

Robert Rosenheck

Psychiatric Services, 2007

View PDFchevron_right

Antipsychotic management in primary care: a longitudinal population-based study

Sally Sheard

medRxiv (Cold Spring Harbor Laboratory), 2024

View PDFchevron_right

Antipsychotic Drug Utilization and Adverse Drug Reaction Profiling in Patients With Schizophrenia at a Tertiary Care Hospital in Western India

Raakhi Tripathi

Cureus

View PDFchevron_right

Predictors of antipsychotic dose changes in the CATIE schizophrenia trial

Robert Rosenheck

Psychiatry Research, 2012

View PDFchevron_right

Resurgence of Long-Acting Antipsychotic Formulations

Steven Siegel

Current Psychiatry Reports, 2010

View PDFchevron_right

Delay to first antipsychotic medication in schizophrenia: impact on symptomatology and clinical course of illness

Gretchen Haas

Journal of Psychiatric Research, 1998

View PDFchevron_right

Real World" Atypical Antipsychotic Prescribing Practices in Public Child and Adolescent Inpatient Settings

Peter Jensen

Schizophrenia Bulletin, 2002

View PDFchevron_right